| Product Code: ETC12773075 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan NSCLC Therapeutics Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan NSCLC Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan NSCLC Therapeutics Market - Industry Life Cycle |
3.4 Jordan NSCLC Therapeutics Market - Porter's Five Forces |
3.5 Jordan NSCLC Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Jordan NSCLC Therapeutics Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 Jordan NSCLC Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Jordan NSCLC Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Jordan NSCLC Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer (NSCLC) in Jordan |
4.2.2 Advancements in NSCLC treatment options and technologies |
4.2.3 Growing demand for personalized medicine and targeted therapies in NSCLC treatment |
4.3 Market Restraints |
4.3.1 High cost associated with NSCLC therapeutics and treatments |
4.3.2 Limited access to advanced NSCLC treatments in certain regions of Jordan |
5 Jordan NSCLC Therapeutics Market Trends |
6 Jordan NSCLC Therapeutics Market, By Types |
6.1 Jordan NSCLC Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan NSCLC Therapeutics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Jordan NSCLC Therapeutics Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 Jordan NSCLC Therapeutics Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021 - 2031F |
6.1.5 Jordan NSCLC Therapeutics Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.6 Jordan NSCLC Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2 Jordan NSCLC Therapeutics Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 Jordan NSCLC Therapeutics Market Revenues & Volume, By Pembrolizumab, 2021 - 2031F |
6.2.3 Jordan NSCLC Therapeutics Market Revenues & Volume, By Erlotinib, 2021 - 2031F |
6.2.4 Jordan NSCLC Therapeutics Market Revenues & Volume, By Cisplatin, 2021 - 2031F |
6.2.5 Jordan NSCLC Therapeutics Market Revenues & Volume, By Stereotactic Body Radiation, 2021 - 2031F |
6.3 Jordan NSCLC Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Jordan NSCLC Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Jordan NSCLC Therapeutics Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Jordan NSCLC Therapeutics Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.3.5 Jordan NSCLC Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Jordan NSCLC Therapeutics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Jordan NSCLC Therapeutics Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.3 Jordan NSCLC Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.4 Jordan NSCLC Therapeutics Market Revenues & Volume, By Advanced Cancer Treatment, 2021 - 2031F |
6.4.5 Jordan NSCLC Therapeutics Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
7 Jordan NSCLC Therapeutics Market Import-Export Trade Statistics |
7.1 Jordan NSCLC Therapeutics Market Export to Major Countries |
7.2 Jordan NSCLC Therapeutics Market Imports from Major Countries |
8 Jordan NSCLC Therapeutics Market Key Performance Indicators |
8.1 Patient survival rates post NSCLC treatment |
8.2 Adoption rate of personalized medicine in NSCLC treatment |
8.3 Number of clinical trials and research studies conducted in Jordan related to NSCLC therapeutics |
8.4 Rate of hospital and healthcare facility investments in advanced NSCLC treatment technologies |
8.5 Patient satisfaction and quality of life improvements post NSCLC treatment |
9 Jordan NSCLC Therapeutics Market - Opportunity Assessment |
9.1 Jordan NSCLC Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Jordan NSCLC Therapeutics Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 Jordan NSCLC Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Jordan NSCLC Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Jordan NSCLC Therapeutics Market - Competitive Landscape |
10.1 Jordan NSCLC Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Jordan NSCLC Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here